By Allan Maurer (TechJournal South)

CHARLESTON, SC—Sabal Medial Inc.,which is developing a medication tracking system using bar code verification, has raised its first institutional round of $2.68 million led by Massachusetts-based Nexus Medical Partners and its German affiliate, Medicis Ventures Management GmbH of Munich.

The company’s existing investors, led by SC Launch! of South Carolina, also participated.

While the company did not disclose the amount of the investment, Thompson Financial’s PE Hub reports that the company called down $1.28 million of a $2.68 million B round. Regulatory filings frequently lag closing of actual full round amounts. The company says “it successfully closed its first institutional investment financing.”

Gregory Zaic, a senior partner of Nexus, will join the Sabal board.

“The Sabal system provides the last vital link in the error-free administration of drugs to hospital patients and will play a key role in reducing medication errors and the costs of administering them”, Zaic commented. “Such errors now cost US hospitals $2 billion per year treating their patients’ preventable adverse drug events,” Zaic continued.


Sabal Medical was initially recruited to South Carolina from Seattle, Washington in late 2006 by an investment from SC Launch!, a South Carolina state-funded source of seed investment capital.

Since then, Sabal has successfully produced and demonstrated a prototype version of their flagship patient safety product, MedCenter, to several eastern US hospitals, and is on target to deliver a commercial version later this year.

MedCenter is a mobile medication cart that uniquely provides nurses with secure and audited bedside access to patient medications through an innovative combination of electro-mechanical control coupled with computer software, and in a footprint small enough to easily fit into a patient’s hospital room. The goal is to help eliminate medication errors and increase nursing efficiency.

On the Web: sabalmedical.com